Krystal Biotech KRYS
NASDAQ KRYS
$328.26 +2.95 (+0.91%)
As of: Oct 2, 2026 · 10:31 AM EDT

Krystal Biotech (KRYS) Non Operating Interest Expenses (2021)

Updated

Krystal Biotech (KRYS) recorded Non Operating Interest Expenses of $1.49 million in FY2021.

Analysis

Krystal Biotech (KRYS) Non Operating Interest Expenses (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Krystal Biotech 9.84 Bn 6.61 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 1.49 Mn
API Access

Krystal Biotech Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KRYS&period=max&api_key=YOUR_API_KEY